Download PDF
Semin Liver Dis 2001; 21(3): 373-384
DOI: 10.1055/s-2001-17552
Copyright © 2001 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Extracellular Matrix Degradation and the Role of Hepatic Stellate Cells

R. Christopher Benyon, Michael J.P. Arthur
  • Liver Research Group, Infection, Inflammation and Repair Division, School of Medicine, University of Southampton, Southampton, United Kingdom
Further Information

Publication History

Publication Date:
01 October 2001 (online)

    Permissions and Reprints

ABSTRACT

Following liver injury, hepatic stellate cells (HSCs) become activated and express a combination of matrix metalloproteinases (MMPs) and their specific tissue inhibitors (TIMPs). In the early phases of liver injury (and primary cell culture), HSCs transiently express MMP-3, MMP-13, and uroplasminogen activator (uPA) and exhibit a matrix-degrading phenotype. In the later stages of liver injury and HSC activation, the pattern changes and the cells express a combination of MMPs that have the ability to degrade normal liver matrix, while inhibiting degradation of the fibrillar collagens that accumulate in liver fibrosis. This pattern is characterized by the combination of pro-MMP-2 and membrane type 1 (MT1)-MMP expression, which drive pericellular generation of active MMP-2 and local degradation of normal liver matrix. In addition there is a marked increase in expression of TIMP-1 leading to a more global inhibition of degradation of fibrillar liver collagens by interstitial collagenases (MMP-1/MMP-13). These pathways play a significant role in the progression of liver fibrosis. Following cessation of liver injury, the pattern reverses and TIMP-1 in particular is rapidly downregulated. This phase is characterized by increasing activity of collagenases, degradation of liver matrix, and regression of liver fibrosis.

KEYWORD

Cirrhosis - liver fibrosis - matrix degradation - matrix metalloproteinases - tissue inhibitor of metalloproteinases

REFERENCES

  • 1 Nagase H, Woessner Jr F J. Matrix metalloproteinases.  J Biol Chem . 1999;  30 21491-21494
    PubMedGoogle Scholar
  • 2 Quantin B, Murphy G, Breathnach R. Pump-1 cDNA codes for a protein with characteristics similar to those of classical collagenase family members.  Biochemistry . 1989;  28 5327-5334
    CrossrefPubMedGoogle Scholar
  • 3 Banyai L, Patthy L. Evidence for the involvement of type II domains in collagen binding by 72kDa type IV procollagenase.  FEBS Lett . 1991;  282 23-25
    CrossrefPubMedGoogle Scholar
  • 4 Aimes R T, Quigley J P. Matrix metalloproteinase-2 is an interstitial collagenase-inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3/4- and 1/4-length fragments.  J Biol Chem . 1995;  270 5872-5876
    CrossrefPubMedGoogle Scholar
  • 5 Holmbeck K, Bianco P, Caterina J. MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover.  Cell . 1999;  99 81-92
    CrossrefPubMedGoogle Scholar
  • 6 Ohuchi E, Imai K, Fujii Y, Sato H, Seiki M, Okada Y. Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules.  J Biol Chem . 1997;  272 2446-2451
    CrossrefPubMedGoogle Scholar
  • 7 Quinn C O, Scott D K, Brinckerhoff C E, Matrisian L M, Jeffrey J J, Partridge N C. Rat collagenase. Cloning, amino acid sequence comparison, and parathyroid hormone regulation in osteoblastic cells.  J Biol Chem . 1990;  265 22342-22347
    PubMedGoogle Scholar
  • 8 Henriet P, Rousseau G G, Eeckhout Y. Cloning and sequencing of mouse collagenase cDNA-divergence of mouse and rat collagenases from the other mammalian collagenases.  FEBS Lett . 1992;  310 175-178
    CrossrefPubMedGoogle Scholar
  • 9 Mitchell P G, Magna H A, Reeves L M. Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage.  J Clin Invest . 1996;  97 761-768
    CrossrefPubMedGoogle Scholar
  • 10 Knauper V, Lopezotin C, Smith B, Knight G, Murphy G. Biochemical characterization of human collagenase-3.  J Biol Chem . 1996;  271 1544-1550
    CrossrefPubMedGoogle Scholar
  • 11 Krane S M, Byrne M H, Lemaitre V. Different collagenase gene products have different roles in degradation of type I collagen.  J Biol Chem . 1996;  271 28509-28515
    CrossrefPubMedGoogle Scholar
  • 12 Vater C A, Harris Jr D E, Siegel R C. Native cross-links in collagen fibrils induce resistance to human synovial collagenase.  Biochem J . 1979;  181 639-645
    PubMedGoogle Scholar
  • 13 Seiki M. Membrane-type matrix metalloproteinases.  APMIS . 1999;  107 137-143
    PubMedGoogle Scholar
  • 14 Gruber B L, Marchee M J, Suzuki K, Schwartz L B, Okada Y, Nagase H, Ramamurthy N S. Synovial procollagenase activation by human mast cell tryptase dependence upon matrix metalloproteinase 3 activation.  J Clin Invest . 1989;  84 1657-1662
    PubMedGoogle Scholar
  • 15 Okada Y, Nakanishi I. Activation of matrix metalloproteinase 3 (stromelysin) and matrix metalloproteinase 2 (gelatinase) by human neutrophil elastase and cathepsin G.  FEBS Lett . 1989;  249 353-356
    CrossrefPubMedGoogle Scholar
  • 16 Irigoyen J P, Munoz-Canoves P, Montero L, Koziczak M, Nagamine Y. The plasminogen activator system: biology and regulation.  Cell Mol Life Sci . 1999;  56 104-132
    CrossrefPubMedGoogle Scholar
  • 17 Suzuki K, Enghild J J, Morodomi T, Salvesen G, Nagase H. Mechanisms of activation of tissue procollagenase by matrix metalloproteinase 3 (stromelysin).  Biochemistry . 1990;  29 10261-10270
    CrossrefPubMedGoogle Scholar
  • 18 Murphy G, Stanton H, Cowell S. Mechanisms for pro matrix metalloproteinase activation.  APMIS . 1999;  109 38-44
    PubMedGoogle Scholar
  • 19 Sato H, Kinoshita T, Takino T, Nakayama K, Seiki M. Activation of a recombinant membrane type 1-matrix metalloproteinase (MT1-MMP) by furin and its interaction with tissue inhibitor of metalloproteinases (TIMP)-2.  FEBS Lett . 1996;  393 101-104
    CrossrefPubMedGoogle Scholar
  • 20 Sato H, Takino T, Okada Y. A matrix metalloproteinase expressed on the surface of invasive tumour cells.  Nature . 1994;  370 61-65
    CrossrefPubMedGoogle Scholar
  • 21 Strongin A Y, Collier I, Bannikov G, Marmer B L, Grant G A, Goldberg G I. Mechanism of cell surface activation of 72-kDa type IV collagenase-isolation of the activated form of the membrane metalloprotease.  J Biol Chem . 1995;  270 5331-5338
    CrossrefPubMedGoogle Scholar
  • 22 Butler G S, Butler M J, Atkinson S J. The TIMP2 membrane type 1 metalloproteinase ``receptor'' regulates the concentration and efficient activation of progelatinase A. A kinetic study.  J Biol Chem . 1998;  273 871-880
    CrossrefPubMedGoogle Scholar
  • 23 Ward R V, Atkinson S J, Slocombe P M, Docherty A JP, Reynolds J J, Murphy G. Tissue inhibitor of metalloproteinases-2 inhibits the activation of 72kDa progelatinase by fibroblast membranes.  Biochim Biophys Acta . 1991;  1079 242-246
    PubMedGoogle Scholar
  • 24 Deryugina E I, Ratnikov B, Monosov E. MT1-MMP initiates activation of pro-MMP-2 and integrin alpha beta 3 promotes maturation of MMP-2 in breast carcinoma cells.  Exp Cell Res . 2001;  263 209-223
    CrossrefPubMedGoogle Scholar
  • 25 Cowell S, Knauper V, Stewart M L. Induction of matrix metalloproteinase activation cascades based on membrane type I matrix metalloproteinase.  Biochem J . 1998;  331 453-458
    PubMedGoogle Scholar
  • 26 Knauper V, Will H, Lopez-Otin C. Cellular mechanisms for human procollagenase-3 (MMP-13) activation-evidence that MT1-MMP (MMP-14) and gelatinase A (MMP-2) are able to generate activate enzyme.  J Biol Chem . 1996;  271 17124-17131
    CrossrefPubMedGoogle Scholar
  • 27 Balbin M, Pendas A M, Uria J A, Jimenez M G, Freije J P, Lopez-Otin C. Expression and regulation of collagenase-3 (MMP-13) in human malignant tumors.  APMIS . 1999;  107 45-53
    PubMedGoogle Scholar
  • 28 Uria J A, Jimenez M G, Balbin M, Freije J MP, Lopez-Otin C. Differential effects of transforming growth factor-beta on the expression of collagenase-1 and collagenase-3 in human fibroblasts.  J Biol Chem . 1998;  273 9769-9777
    CrossrefPubMedGoogle Scholar
  • 29 Pan L, Eckhoff C, Brinckerhoff C E. Suppression of collagenase gene expression by all-trans and 9-cis retinoic acid is ligand dependent and requires both RARs and RXRs.  J Cell Biochem . 1995;  57 575-589
    CrossrefPubMedGoogle Scholar
  • 30 Bigg H F, Cawston T E. All-trans-retinoic acid interacts synergistically with basic fibroblast growth factor and epidermal growth factor to stimulate the production of tissue inhibitor of metalloproteinases from fibroblasts.  Arch Biochem Biophys . 1995;  319 74-83
    CrossrefPubMedGoogle Scholar
  • 31 Okuno M, Sato T, Kitamoto T. Increased 9, 13-di-cis-retinoic acid in rat hepatic fibrosis: implication for a potential link between retinoid loss and TGF-beta mediated fibrogenesis in vivo.  J Hepatol . 1999;  30 1073-1080
    CrossrefPubMedGoogle Scholar
  • 32 Overall C M, Wrana J L, Sudek J. Independent regulation of collagenase, 72kD progelatinase, and metalloendoproteinase inhibitor expression in human fibroblasts by transforming growth factor-beta.  J Biol Chem . 1989;  264 1860-1869
    PubMedGoogle Scholar
  • 33 Marti H P, Lee L, Kashgarian M, Lovett D H. Transforming growth factor-beta 1 stimulates glomerular mesangial cell synthesis of the 72-kD type IV collagenase.  Am J Pathol . 1994;  144 82-94
    PubMedGoogle Scholar
  • 34 Miralles F, Battelino T, Czernichow P, Scharfmann R. TGF-beta plays a key role in morphogenesis of the pancreatic islets of Langerhans by controlling the activity of the matrix metalloproteinase MMP-2.  J Cell Biol . 1998;  143 827-836
    CrossrefPubMedGoogle Scholar
  • 35 Riikonen T, Westermarck J, Koivisto L, Broberg A, Kahari V M, Heino J. Integrin alpha 2 beta 1 is a positive regulator of collagenase (MMP-1) and collagen alpha 1(I) gene expression.  J Biol Chem . 1995;  270 13548-13552
    CrossrefPubMedGoogle Scholar
  • 36 Seltzer J L, Lee A Y, Akers K T, Sudbeck B, Southon E A, Wayner E A, Eisen A Z. Activation of 72-kDa type IV collagenase/gelatinase by normal fibroblasts in collagen lattices is mediated by integrin receptors but is not related to lattice contraction.  Exp Cell Res . 1994;  213 365-374
    CrossrefPubMedGoogle Scholar
  • 37 Theret N, Lehti K, Musso O, Clement B. MMP2 activation by collagen I and concanavalin A in cultured human hepatic stellate cells.  Hepatology . 1999;  30 462-468
    CrossrefPubMedGoogle Scholar
  • 38 Takahara T, Furui K, Funaki J. Increased expression of matrix metalloproteinase-II in experimental liver fibrosis in rats.  Hepatology . 1995;  21 787-795
    CrossrefPubMedGoogle Scholar
  • 39 Gomez D E, Alonso D F, Yoshiji H, Thorgeirsson U P. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions.  Eur J Cell Biol . 1997;  74 111-122
    PubMedGoogle Scholar
  • 40 Will H, Atkinson S J, Butler G S, Smith B, Murphy G. The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation-regulation by TIMP-2 and TIMP-3.  J Biol Chem . 1996;  271 17119-17123
    CrossrefPubMedGoogle Scholar
  • 41 Murphy G, Willenbrock F. Tissue inhibitors of matrix metalloproteinases.  Meth Enzymol . 1995;  248 496-510
    PubMedGoogle Scholar
  • 42 Caterina N C, Windsor L J, Yermovsky A E. Replacement of conserved cysteines in human tissue inhibitor of metalloproteinases-1.  J Biol Chem . 1997;  272 32141-32149
    CrossrefPubMedGoogle Scholar
  • 43 Goldberg G I, Strongin A, Collier I E, Genrich L T, Marmer B L. Interaction of 92-kDa type-IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin.  J Biol Chem . 1992;  267 4583-4591
    PubMedGoogle Scholar
  • 44 Howard E W, Banda M J. Binding of tissue inhibitor of metalloproteinases 2 to two distinct sites on human 72-kDa gelatinase.  J Biol Chem . 1991;  266 17972-17977
    PubMedGoogle Scholar
  • 45 Leco K J, Khokha R, Pavloff N. Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues.  J Biol Chem . 1994;  269 9352-9360
    PubMedGoogle Scholar
  • 46 Edwards D R, Murphy G, Reynolds J J. Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor.  EMBO J . 1987;  6 1899-1904
    PubMedGoogle Scholar
  • 47 Mackay A R, Ballin M, Pelina M D. Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines.  Invasion Metastasis . 1992;  12 168-184
    PubMedGoogle Scholar
  • 48 Zafarullah M, Su S, Martel-Pelletier J. Tissue inhibitor of metalloproteinase-2 (TIMP-2) mRNA is constitutively expressed in bovine, human normal, and osteoarthritic articular chondrocytes.  J Cell Biochem . 1996;  60 211-217
    CrossrefPubMedGoogle Scholar
  • 49 Hayakawa T, Yamashita K, Tanzawa K, Uchijima E, Iwata K. Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells-a possible new growth factor in serum.  FEBS Lett . 1992;  298 29-32
    CrossrefPubMedGoogle Scholar
  • 50 Stetlerstevenson W G, Bersch N, Golde D W. Tissue inhibitor of metalloproteinase-2 (TIMP-2) has erythroid- potentiating activity.  FEBS Lett . 1992;  296 231-234
    CrossrefPubMedGoogle Scholar
  • 51 Nemeth J A, Rafe A, Steiner M, Goolsby C L. TIMP-2 growth-stimulatory activity: a concentration- and cell type-specific response in the presence of insulin.  Exp Cell Res . 1996;  224 110-115
    CrossrefPubMedGoogle Scholar
  • 52 Hayakawa T, Yamashita K, Ohuchi E, Shinagawa A. Cell growth-promoting activity of tissue inhibitor of metalloproteinases-2 (TIMP-2).  J Cell Sci . 1994;  107 2373-2379
    PubMedGoogle Scholar
  • 53 Corcoran M L, Stetlerstevenson W G. Tissue inhibitor of metalloproteinase-2 stimulates fibroblast proliferation via a cAMP-dependent mechanism.  J Biol Chem . 1995;  270 13453-13459
    CrossrefPubMedGoogle Scholar
  • 54 Chesler L, Golde D W, Bersch N, Johnson M D. Metalloproteinase inhibition and erythroid potentiation are independent activities of tissue inhibitor of metalloproteinases.  Blood . 1995;  86 4506-4515
    PubMedGoogle Scholar
  • 55 Zhao W-Q, Li H, Yamashita K. Cell cycle-associated accumulation of tissue inhibitor of metalloproteinases-1 (TIMP-1) in the nuclei of human gingival fibroblasts.  J Cell Sci . 1998;  111 1147-1153
    PubMedGoogle Scholar
  • 56 Baker A H, George S J, Zaltsman A B, Murphy G, Newby A C. Inhibition of invasion and induction of apoptotic cell death of cancer cell lines by overexpression of TIMP-3.  Br J Cancer . 1998;  79 1347-1355
    PubMedGoogle Scholar
  • 57 Baker A H, Zaltsman A B, George S J, Newby A C. Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro.  J Clin Invest . 1998;  101 1478-1487
    PubMedGoogle Scholar
  • 58 Leco K J, Apte S S, Taniguchi G T, Hawkes S P, Khokha R, Schultz G A, Edwards D R. Murine tissue inhibitor of metalloproteinases-4 (TIMP-4): cDNA isolation and expression in adult mouse tissues.  FEBS Lett . 1997;  401 213-217
    CrossrefPubMedGoogle Scholar
  • 59 Vyas S K, Leyland H, Gentry J, Arthur M JP. Rat hepatic lipocytes synthesize and secrete transin (stromelysin) is expressed in early primary culture.  Gastroenterology . 1995;  109 889-898
    PubMedGoogle Scholar
  • 60 Iredale J P, Goddard S, Murphy G, Benyon R C, Arthur M JP. Tissue inhibitor of metalloproteinase-1 and interstitial collagenase expression in autoimmune chronic active hepatitis and activated human hepatic lipocytes.  Clin Sci . 1995;  89 75-81
    PubMedGoogle Scholar
  • 61 Iredale J P, Benyon R C, Arthur M JP. Tissue inhibitor of metalloproteinase-1 messenger RNA expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis.  Hepatology . 1996;  24 176-184
    PubMedGoogle Scholar
  • 62 Leyland H, Gentry J, Arthur M JP, Benyon R C. The plasminogen-activating system in hepatic stellate cells.  Hepatology . 1996;  24 1172-1178
    CrossrefPubMedGoogle Scholar
  • 63 Benyon R C, Iredale J P, Goddard S, Winwood P J, Arthur M JP. Expression of tissue inhibitor of metalloproteinases-1 and -2 is increased in fibrotic human liver.  Gastroenterology . 1996;  110 821-831
    CrossrefPubMedGoogle Scholar
  • 64 Arthur M JP, Friedman S L, Roll F J, Bissell D M. Lipocytes from normal rat liver release a neutral metalloproteinase that degrades basement membrane (type IV) collagen.  J Clin Invest . 1989;  84 1076-1085
    PubMedGoogle Scholar
  • 65 Benyon R C, Hovell C J, Gaca M DA, Jones E H, Iredale J P, Arthur M JP. Progelatinase A is produced and activated by rat hepatic stellate cells and promotes their proliferation.  Hepatology . 1999;  30 977-986
    CrossrefPubMedGoogle Scholar
  • 66 Theret N, Lehti K, Musso O, Clement B. MMP2 activation by collagen I and concanavalin A in cultured human hepatic stellate cells.  Hepatology . 1999;  30 462-468
    CrossrefPubMedGoogle Scholar
  • 67 Olaso E, Eng F, Lin C, Yancopoulos G, Friedman S L. The discoidin domain receptor 2 (DDR2) is induced during stellate cell activation, mediates cell growth and matrix metalloproteinase 2 expression, and is regulated by extracellular matrix.  Hepatology . 1999;  30 1009
    PubMedGoogle Scholar
  • 68 Godichaud S, Krisa S, Couronne B. Deactivation of cultured human liver myofibroblasts by trans-resveratrol, a grapevine-derived polyphenol.  Hepatology . 2000;  31 922-931
    CrossrefPubMedGoogle Scholar
  • 69 Herbst H, Heinrichs O, Schuppan D, Milani S, Stein H. Temporal and spatial patterns of transin/stromelysin RNA expression following toxic injury in rat liver.  Virchows Arch [B] . 1991;  60 295-300
    PubMedGoogle Scholar
  • 70 Knittel T, Mehde M, Grundmann A, Saile B, Scharf J G, Ramadori G. Expression of matrix metalloproteinases and their inhibitors during hepatic tissue repair in the rat.  Histochem Cell Biol . 2000;  113 443-453
    PubMedGoogle Scholar
  • 71 Nieto N, Dominguez-Rosales J A, Fontana L. Rat hepatic stellate cells contribute to the acute-phase response with increased expression of alpha1(I) and alpha1(IV) collagens, tissue inhibitor of metalloproteinase-1, and matrix-metalloproteinase-2 messenger RNAs.  Hepatology . 2001;  33 597-607
    CrossrefPubMedGoogle Scholar
  • 72 Kim T-H, Mars W M, Stolz D B, Petersen B E, Michalopoulos G K. Extracellular matrix remodeling at the early stages of liver regeneration in the rat.  Hepatology . 1997;  26 896-904
    CrossrefPubMedGoogle Scholar
  • 73 Kim T H, Mars W M, Stolz D B, Michalopoulos G K. Expression and activation of pro-MMP-2 and pro-MMP-9 during rat liver regeneration.  Hepatology . 2000;  31 75-82
    CrossrefPubMedGoogle Scholar
  • 74 Shimizu M, Hara A, Okuno M. Mechanism of retarded liver regeneration in plasminogen activator-deficient mice: impaired activation of hepatocyte growth factor after Fas-mediated massive hepatic apoptosis.  Hepatology . 2001;  33 569-576
    CrossrefPubMedGoogle Scholar
  • 75 Schiff E R, Heathcote J, Dienstag J L. Improvements in liver histology and cirrhosis with extended lamivudine therapy.  Hepatology . 2000;  32 546
    PubMedGoogle Scholar
  • 76 Hammel P, Couvelard A, O'Toole D. Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct.  N Engl J Med . 2001;  344 418-423
    CrossrefPubMedGoogle Scholar
  • 77 Takahara T, Furui K, Yata Y. Dual expression of matrix metalloproteinase-2 and membrane-type 1-matrix metalloproteinase in fibrotic human livers.  Hepatology . 1997;  26 1521-1529
    PubMedGoogle Scholar
  • 78 Herbst H, Wege T, Milani S. Tissue inhibitor of metalloproteinase-1 and -2 RNA expression in rat and human liver fibrosis.  Am J Pathol . 1997;  150 1647-1659
    PubMedGoogle Scholar
  • 79 Yata Y, Takahara T, Furui K, Zhang L P, Jin B, Watanabe A. Spatial distribution of tissue inhibitor of metalloproteinase-1 mRNA in chronic liver disease.  J Hepatol . 1999;  30 425-432
    CrossrefPubMedGoogle Scholar
  • 80 Yoshiji H, Kuriyama S, Miyamoto Y. Tissue inhibitor of metalloproteinases-1 promotes liver fibrosis development in a transgenic mouse model.  Hepatology . 2000;  32 1248-1254
    CrossrefPubMedGoogle Scholar
  • 81 Iredale J P, Benyon R C, Pickering J. Mechanisms of spontaneous resolution of rat liver fibrosis: hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors.  J Clin Invest . 1998;  102 538-549
    CrossrefPubMedGoogle Scholar
  • 82 Hironaka K, Sakaida I, Matsumura Y, Kaino S, Miyamoto K, Okita K. Enhanced interstitial collagenase (matrix metalloproteinase-13) production of Kupffer cell by gadolinium chloride prevents pig serum-induced rat liver fibrosis.  Biochem Biophys Res Commun . 2000;  267 290-295
    CrossrefPubMedGoogle Scholar
  • 83 Watanabe T, Niioka M, Hozawa S. Gene expression of interstitial collagenase in both progressive and recovery phase of rat liver fibrosis induced by carbon tetrachloride.  J Hepatol . 2000;  33 224-235
    CrossrefPubMedGoogle Scholar
  • 84 Atkinson S J, Patterson M L, Butler M J, Murphy G. Membrane type 1 matrix metalloproteinase and gelatinase A synergistically degrade type 1 collagen in a cell model.  FEBS Lett . 2001;  491 222-226
    CrossrefPubMedGoogle Scholar
      >